For more than 15 years, the Protein Engineering and Cell Therapy Summit (PEGS) of Boston has been the premier networking and professional development event for biotherapeutics drug development research and collaboration.
Charles River is pleased to contribute to the scientific program with three presentations. The recordings are now available for you to view on demand below.
Gene Therapy Products: Is Viral Clearance Needed? What Do the Guidelines Require?
Presented by: Tareq Jaber, PhD, Manager Process Evaluation, Charles River
Assessing Efficacy and Potential Safety Risks of Cell Therapies In Vitro Using Primary and iPSC-Derived Cells
Presented by: Sophie Vermond, Early Discovery Scientist, Immunology, Immuno-oncology and Cell Therapy, Charles River
Specificity Screening of Mabs, scFvs, & CAR Ts Against Expressed Receptors, Heterodimers & Secreted Protein Targets
Presented by: Nick Brown, MSc, Senior North American Business Development Manager, Retrogenix Limited
With industry-leading regulatory expertise and a comprehensive portfolio of products and services, Charles River is your partner for end-to-end development of novel cell therapies, gene therapies, and biotherapeutics for even the most challenging targets. Want to set aside time to meet with our scientists? Simply fill out the form to the right and we’ll be in touch with scheduling options.